Posts circulating on Facebook and Instagram incorrectly claim that the Centers for Disease Control and Prevention is withdrawing its COVID-19 test because it cannot differentiate between the COVID ...
Between 2010 and 2017, there were 327,700 new HIV infections in the United States. Of these, HIV-2 infections accounted for less than 0.03% of the total. It is important to differentiate which HIV ...
In this webinar, our speakers will provide an introduction into the epidemiology of SARS CoV 2, influenza A/B, and RSV, explaining why it is important to detect and differentiate all three viruses in ...
Thinly traded nano cap ADiTx Therapeutics (NASDAQ:ADTX) jumps 86% premarket on robust volume in reaction to its announcement that its AditxtScore test for COVID-19 has been validated in studies ...
Basel, 6 December 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced its plans to launch the SARS-CoV-2 & Flu A/B Rapid Antigen Test for professional use in markets accepting the CE Mark by the ...
This retrospective study evaluated real-world implementation of the updated CDC HIV algorithm in a large US laboratory. Objectives: To understand real-world implementation of the updated CDC HIV ...
Cepheid announced it has received clearance from the Food and Drug Administration (FDA) to market Xpert Norovirus, an in vitro diagnostic test for identification and differentiation of Noroviruses ...
STAFFORD, Texas, Oct. 22, 2019 /PRNewswire/ -- DetectaChem, the global leader in handheld drug and explosive detection technology, in response to overwhelming industry demand, has released the CBD/THC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback